Summary
- Current Price
- As of today, ERAS price is $17.81, up +7.29% on
- Current Price All-Time High
- ERAS price is currently -27.22% below its historical high of $24.47 set on
- Market Cap
- ERAS current market cap is $6B, up +1444.83% over the past 365 days
- PE Ratio
- ERAS PE ratio is unknown
- Revenue
- ERAS current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for ERAS is on
Profile
| Metric | Value |
|---|---|
| Full Name | Erasca, Inc. |
| Ticker | NASDAQ: ERAS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | erasca.com |
| Employees | 103 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $17.81 | |
| Price, 1D Change | +7.29% | |
| $6B | ||
| - | ||
| - | ||
| 1.07 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$0.44 | ||
| EPS, 1Y Change | +36.46% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.44 | ||
| EPS Estimate | N/A | -$0.57 |
| EPS Est. Change | N/A | -29.23% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $17.81 | |
| Price Target | - | $19.50 |
| Price Tgt. Change | - | +9.49% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.75 | -$0.69 | +7.34% | |
| -$0.31 | -$0.44 | -41.85% | |
| -$0.57 | N/A | -29.23% | |
| -$0.54 | N/A | -23.26% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| $428.57K | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $17.81 | |
| $5.25 | ||
| SMA 200 vs Price | -70.54% | |
| $13.32 | ||
| SMA 50 vs Price | -25.23% | |
| 1.07 | ||
| $1.09 | ||
| 71.12 | ||
| 81.75% | ||
| 98.96% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$0.44 | ||
| -$3.11M | ||
| - | ||
| -$131.41M | ||
| - | ||
| -$124.55M | ||
| - | ||
| -$128.30M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.15 | ||
| 10.04 | ||
| 10.04 | ||
| - | ||
| - | ||
| 36.83 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 16.96 | ||
| -41.19 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $325.17M | ||
| $276.08M | ||
| $407.46M | ||
| $286.24M | ||
| $82.28M | ||
| $28.51M | ||
| $47.14M | ||
| $5.07M | ||
| $981.00K |
Expenses
| Metric | Date | Value |
|---|---|---|
| $124.55M | ||
| $128.30M | ||
| $3.11M | ||
| $0.00 | ||
| $3.11M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$95.46M | ||
| $100.43M | ||
| $1.10M | ||
| $128.00K | ||
| -$95.58M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| JP Morgan | → | |
| Guggenheim | → | |
| Piper Sandler | → | |
| Mizuho | → | |
| HC Wainwright & Co. | → | |
| Clear Street | → | |
| HC Wainwright & Co. | → | |
| Piper Sandler | → | |
| HC Wainwright & Co. | → | |
| Piper Sandler |
Analyst sentiment
Institutional ownership
Screeners with ERAS
FAQ
What is the ticker symbol for Erasca, Inc.?
The ticker symbol for Erasca, Inc. is NASDAQ:ERAS
Does Erasca, Inc. pay dividends?
No, Erasca, Inc. does not pay dividends
What sector is Erasca, Inc. in?
Erasca, Inc. is in the Healthcare sector
What industry is Erasca, Inc. in?
Erasca, Inc. is in the Biotechnology industry
What country is Erasca, Inc. based in?
Erasca, Inc. is headquartered in United States
When did Erasca, Inc. go public?
Erasca, Inc. initial public offering (IPO) was on July 16, 2021
Is Erasca, Inc. in the S&P 500?
No, Erasca, Inc. is not included in the S&P 500 index
Is Erasca, Inc. in the NASDAQ 100?
No, Erasca, Inc. is not included in the NASDAQ 100 index
Is Erasca, Inc. in the Dow Jones?
No, Erasca, Inc. is not included in the Dow Jones index
When was Erasca, Inc. last earnings report?
Erasca, Inc.'s most recent earnings report was on March 12, 2026
When does Erasca, Inc. report earnings?
The next expected earnings date for Erasca, Inc. is May 13, 2026
Data Sources & References
- ERAS Official Website www.erasca.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1761918/000119312526104150/0001193125-26-104150-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1761918/000119312526104150/0001193125-26-104150-index.htm
- ERAS Profile on Yahoo Finance finance.yahoo.com/quote/ERAS
- ERAS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/eras